Preview | Issue Date | Title | Author(s) |
| 2012 | A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial | Richmond, P.; Nissen, M.; Marshall, H.; Lambert, S.; Roberton, D.; Gruber, W.; Jones, T.; Arora, A. |
| 2006 | A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years | Marshall, H.; Nolan, T.; Roberton, D.; Richmond, P.; Lambert, S.; Jacquet, J.; Schuerman, L. |
| 2007 | A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants | Nolan, T.; Lambert, S.; Roberton, D.; Marshall, H.; Richmond, P.; Streeton, C.; Poolman, J.; Boutriau, D. |
| 2012 | A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers | McVernon, J.; Nolan, T.; Richmond, P.; Reynolds, G.; Nissen, M.; Lambert, S.; Marshall, H.; Papa, T.; Rehm, C. |
| 2007 | DTPa-HBV-IPV vaccine for primary vaccination of infants | Nolan, T.; Lambert, S.; Roberton, D.; Marshall, H.; Richmond, P.; Streeton, C. |
| 2015 | Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in Australia | Marshall, H.; Richmond, P.; Nissen, M.; Lambert, S.; Booy, R.; Reynolds, G.; Sebastian, S.; Pride, M.; Jansen, K.; Anderson, A.; Scully, I. |
| 2011 | Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age | Booy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Heron, L.; Lambert, S.; Caubet, M.; Mesaros, N.; Boutriau, D. |
| 2012 | Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials | Bryant, K.; McVernon, J.; Marchant, C.; Nolan, T.; Marshall, G.; Richmond, P.; Marshall, H.; Nissen, M.; Lambert, S.; Aris, E.; Mesaros, N.; Miller, J. |
| 2010 | Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial | Nolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M. |
| 2006 | Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A review | Jacquet, J.; Begue, P.; Grimprel, E.; Reinert, P.; Sandbu, S.; Silfverdal, S.; Faldella, G.; Nolan, T.; Lambert, S.; Richmond, P.; Marshall, H.; Roberton, D.; Schuerman, L. |
| 2013 | Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents | Lambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M. |
| 2018 | The impact of the 13 valent conjugate pneumococcal vaccine on pneumococcal serotypes causing childhood empyema in Australia | Strachan, R.; Beggs, S.; Fearon, D.; Gilbert, G.; Homaira, N.; Lambert, S.; Marshall, H.; Martin, A.; McCallum, G.; McCullagh, A.; McDonald, T.; Mcintyre, P.; Oftadeh, S.; Ranganathan, S.; Suresh, S.; Teoh, L.; Twaij, A.; Wainwright, C.; Wong, M.; Snelling, T.; et al.; The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting 2018 (23 Mar 2018 - 27 Mar 2018 : Adelaide, AUSTRALIA) |
| 2013 | Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlers | Booy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J. |